Published in Circulation on August 11, 2003
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med (2009) 2.17
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest (2013) 1.61
Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation. J Am Soc Nephrol (2010) 1.60
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol (2011) 1.57
Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One (2007) 1.51
The role of adaptive T cell immunity in atherosclerosis. J Lipid Res (2008) 1.43
Innate and adaptive immunity in atherosclerosis. Semin Immunopathol (2009) 1.40
Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation (2011) 1.20
Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.12
Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation (2010) 1.11
Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma. Am J Respir Crit Care Med (2009) 1.10
The expression and functions of toll-like receptors in atherosclerosis. Mediators Inflamm (2010) 1.07
Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am J Pathol (2004) 1.06
Regulatory T cells in cardiovascular diseases. Nat Rev Cardiol (2015) 1.04
T cells in atherosclerosis. Int Immunol (2013) 1.03
Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res Ther (2004) 1.02
Statins induce the accumulation of regulatory T cells in atherosclerotic plaque. Mol Med (2012) 1.02
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100. Front Immunol (2013) 1.02
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice. BMC Immunol (2010) 1.00
Circulating Th22 and Th9 levels in patients with acute coronary syndrome. Mediators Inflamm (2013) 0.99
Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis. Circ Res (2010) 0.97
Treating atherosclerosis with regulatory T cells. Arterioscler Thromb Vasc Biol (2014) 0.95
CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice. J Clin Immunol (2012) 0.94
Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment. Front Endocrinol (Lausanne) (2013) 0.93
Lymphocytes in atherosclerosis. Arterioscler Thromb Vasc Biol (2015) 0.90
Cytokine network and T cell immunity in atherosclerosis. Semin Immunopathol (2009) 0.90
Beyond vascular inflammation--recent advances in understanding atherosclerosis. Cell Mol Life Sci (2015) 0.90
The role of the vascular dendritic cell network in atherosclerosis. Am J Physiol Cell Physiol (2013) 0.87
Incretin hormones as immunomodulators of atherosclerosis. Front Endocrinol (Lausanne) (2012) 0.86
TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice. PLoS One (2012) 0.85
Regulatory T cells and Atherosclerosis. J Clin Exp Cardiolog (2012) 0.85
Current advances in understanding of immunopathology of atherosclerosis. Virchows Arch (2010) 0.85
Molecular chaperones and heat shock proteins in atherosclerosis. Am J Physiol Heart Circ Physiol (2011) 0.84
T helper cell polarization in healthy people: implications for cardiovascular disease. J Cardiovasc Transl Res (2013) 0.82
Vaccination to modulate atherosclerosis. Autoimmunity (2015) 0.81
Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis - emerging perspectives of immunomodulation. Arch Med Sci (2013) 0.81
T lymphocyte autoreactivity in inflammatory mechanisms regulating atherosclerosis. ScientificWorldJournal (2012) 0.80
CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. J Am Heart Assoc (2014) 0.80
Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells. Transl Res (2014) 0.78
Vitamin D status and peripheral arterial disease: evidence so far. Vasc Health Risk Manag (2011) 0.78
Immunological aspects of atherosclerosis. Semin Immunopathol (2013) 0.77
Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis. Clin Exp Immunol (2015) 0.77
Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes. Mediators Inflamm (2013) 0.76
Helper T cells and atherosclerosis: the cytokine web. Postgrad Med J (2005) 0.76
Changes in CD4(+)CD25(+) Tregs in the pathogenesis of atherosclerosis in ApoE(-/-) mice. Exp Biol Med (Maywood) (2017) 0.75
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment. BMC Cardiovasc Disord (2016) 0.75
Redox homeostasis, T cells and kidney diseases: three faces in the dark. Clin Kidney J (2015) 0.75
Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells. Am J Physiol Heart Circ Physiol (2017) 0.75
Regulatory B cells, interleukin-10, and atherosclerosis. Curr Opin Lipidol (2015) 0.75
Deletion of Batf3-dependent antigen-presenting cells does not affect atherosclerotic lesion formation in mice. PLoS One (2017) 0.75
Tim-3 inhibits low-density lipoprotein-induced atherogenic responses in human umbilical vein endothelial cells. Oncotarget (2017) 0.75
Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation (2004) 5.28
Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med (2006) 4.28
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation (2008) 3.69
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation (2003) 3.55
Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity (2003) 3.28
Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology (2012) 2.95
B cell depletion reduces the development of atherosclerosis in mice. J Exp Med (2010) 2.79
TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest (2010) 2.32
Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 2.21
Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med (2005) 2.21
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol (2005) 2.20
Lactadherin promotes VEGF-dependent neovascularization. Nat Med (2005) 2.19
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med (2009) 2.17
Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res (2013) 2.05
Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation (2007) 2.00
Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension (2006) 1.99
Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.98
Endothelial microparticles in diseases. Cell Tissue Res (2008) 1.96
Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 1.94
CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol (2008) 1.82
p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res (2005) 1.81
Microparticles, vascular function, and atherothrombosis. Circ Res (2011) 1.78
Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology (2006) 1.78
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol (2007) 1.72
Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology (2012) 1.69
Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ Res (2003) 1.68
Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res (2014) 1.68
Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur Heart J (2012) 1.66
In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J Am Coll Cardiol (2011) 1.65
A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc Res (2012) 1.63
Cellular mechanics and gene expression in blood vessels. J Biomech (2003) 1.63
Transforming growth factor-alpha mediates nuclear factor kappaB activation in strained arteries. Circ Res (2006) 1.58
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol (2011) 1.57
Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res (2007) 1.54
Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens (2002) 1.54
Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation (2004) 1.48
Circulating microparticles may influence early carotid artery remodeling. J Hypertens (2010) 1.45
Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circ Res (2002) 1.44
Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers. Circulation (2010) 1.44
The role of adaptive T cell immunity in atherosclerosis. J Lipid Res (2008) 1.43
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med (2013) 1.43
Post-ischaemic neovascularization and inflammation. Cardiovasc Res (2008) 1.41
Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest (2003) 1.40
Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol (2004) 1.37
Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice. J Biol Chem (2002) 1.36
Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension (2007) 1.36
Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res (2010) 1.36
Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol (2006) 1.34
Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study. Arterioscler Thromb Vasc Biol (2007) 1.34
Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events. J Am Coll Cardiol (2010) 1.34
Role of dendritic cells in the generation of regulatory T cells. Semin Immunol (2004) 1.29
Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes. J Am Coll Cardiol (2005) 1.28
Evidence of a role for lactadherin in Alzheimer's disease. Am J Pathol (2007) 1.28
Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol (2006) 1.24
Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. FASEB J (2004) 1.22
Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes. Circulation (2012) 1.21
The complex role of interleukin-10 in autoimmunity. J Autoimmun (2003) 1.19
Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol (2010) 1.18
Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost (2010) 1.17
Live Staphylococcus aureus and bacterial soluble factors induce different transcriptional responses in human airway cells. Physiol Genomics (2004) 1.17
Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16. Br J Haematol (2008) 1.16
Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation (2003) 1.14
In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension (2007) 1.12
A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation. J Immunol (2003) 1.12
Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood (2003) 1.12